FDA Adverse Event Malfunction Summary report: N

ENERGEN

MDR report key: 3212422 · Received July 9, 2013

Report

Report Number
2124215-2013-08555
Event Type
Malfunction
Date Received
July 9, 2013
Date of Event
May 16, 2013
Report Date
June 28, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY A THOROUGH PRODUCT ANALYSIS WAS PERFORMED. VISUAL INSPECTION NOTED A HOLE IN THE LEFT VENTRICULAR SEAL PLUG. X-RAY INSPECTION NOTED THE PLASMA FUSE WAS BLOWN. THE BATTERY STATUS WAS END OF LIFE (EOL). IT WAS NOTED THE EOL STATUS WAS SET BY A 45 SECOND CHARGE TIME. THE CAUSE OF THE 45 SECOND CHARGE TIME AND THE EOL BATTERY STATUS WAS ELECTRICAL OVERSTRESS DAMAGE DUE TO THE DEVICE FIRING A SHOCK INTO A SHORTED LEAD.

Additional Manufacturer Narrative · 1

THE PRODUCT IS EXPECTED TO BE RETURNED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON RETURN AND COMPLETION OF ANALYSIS.

Description of Event or Problem · 1

--

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A ROUTINE DEVICE UPGRADE PROCEDURE, THE SENSING DECREASED ON THE RIGHT VENTRICULAR (RV) LEAD. AFTER THE SENSITIVITY WAS REPROGRAMMED, VENTRICULAR FIBRILLATION (VF) COULD NOT BE DETECTED. AS A RESULT, A NEW PACE/SENSE LEAD WAS IMPLANTED. WHEN A 21J SHOCK WAS DELIVERED, THE VR WAS NOT ELIMINATED. ADDITIONALLY, AN ERROR MESSAGE APPEARED STATING THE DEVICE BATTERY WAS DEPLETED. A SECOND DEVICE (P143/104368) WITH THE SAME RV LEAD WAS IMPLANTED AND THE ERROR MESSAGE PERSISTED. THE CHRONIC RV LEAD WAS SURGICALLY ABANDONED. A THIRD DEVICE WAS IMPLANTED WITH A NEW RV LEAD AND THE DEVICE AND LEAD BOTH OPERATED APPROPRIATELY. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
313421 ENERGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND P143

Patients

Seq Age Sex Outcome Treatment
1